|
SLC9A7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.258400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.287390E-01 |
| Normal-vs-Stage2 |
9.909200E-01 |
| Normal-vs-Stage3 |
5.251400E-01 |
| Normal-vs-Stage4 |
7.600000E-01 |
| Stage1-vs-Stage2 |
4.927400E-01 |
| Stage1-vs-Stage3 |
2.637600E-01 |
| Stage1-vs-Stage4 |
5.863600E-01 |
| Stage2-vs-Stage3 |
6.230400E-01 |
| Stage2-vs-Stage4 |
7.693800E-01 |
| Stage3-vs-Stage4 |
9.981800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.653000E-01 |
| Normal-vs-AfricanAmerican |
9.283600E-01 |
| Normal-vs-Asian |
3.431400E-01 |
| Caucasian-vs-AfricanAmerican |
7.315400E-01 |
| Caucasian-vs-Asian |
8.066400E-01 |
| AfricanAmerican-vs-Asian |
6.950000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.449690E-02 |
| Normal-vs-Female |
3.415500E-03 |
| Male-vs-Female |
7.78330000000826E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.255000E-01 |
| Normal-vs-Extreme_Weight |
1.346080E-02 |
| Normal-vs-Obese |
1.771950E-01 |
| Normal-vs-Extreme_Obese |
9.063300E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.933800E-01 |
| Normal_Weight-vs-Obese |
1.479170E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.530600E-01 |
| Extreme_Weight-vs-Obese |
8.961400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.966600E-01 |
| Obese-vs-Extreme_Obese |
1.049880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.669020E-01 |
| Normal-vs-Age(41-60Yrs) |
6.901600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.253960E-01 |
| Normal-vs-Age(81-100Yrs) |
8.780700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.001000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.024650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.709800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.327780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.240200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.204200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.107600E-02 |
| Normal-VS-Type2 PRCC |
2.747800E-01 |
| Normal-VS-KIRP CIMP |
3.931800E-02 |
| Normal-VS-Unclassified PRCC |
8.386000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.535800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.631800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.666190E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.097600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.614300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.128200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.476800E-01 |
| Normal-vs-N1 |
2.216000E-01 |
| Normal-vs-N2 |
2.938800E-01 |
| N0-vs-N1 |
1.139990E-01 |
| N0-vs-N2 |
2.542000E-01 |
| N1-vs-N2 |
3.168400E-01 |
|
|
